Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Diabetes. Dec 15, 2014; 5(6): 747-755
Published online Dec 15, 2014. doi: 10.4239/wjd.v5.i6.747
Published online Dec 15, 2014. doi: 10.4239/wjd.v5.i6.747
Is the present cut-point to define type 2 diabetes appropriate in Latin-Americans?
Patricio López-Jaramillo, Carlos Velandia-Carrillo, Martin Aldana-Campos, Dirección de Investigaciones, Clínica de Síndrome Metabólico, Prediabetes y Diabetes, Fundación Oftalmológica de Santander-FOSCAL, 681004 Floridablanca, Colombia
Patricio López-Jaramillo, Diego Gómez-Arbeláez, Instituto de Investigaciones MASIRA, Facultad de Medicina, Universidad de Santander-UDES, 680003 Bucaramanga, Santander, Colombia
Carlos Velandia-Carrillo, Departamento de Medicina Interna, Universidad Autónoma de Bucaramanga, 680003 Bucaramanga, Colombia
Diego Gómez-Arbeláez, División de Endocrinología, Escuela de Medicina, Universidad de Santiago de Compostela, 15782 Santiago de Compostela, España
Author contributions: All the authors equally contributed to this paper.
Correspondence to: Patricio López-Jaramillo, MD, PhD, FACP, Dirección de Investigaciones, Clínica de Síndrome Metabólico, Prediabetes y Diabetes, Fundación Oftalmológica de Santander-FOSCAL, Calle 155A N. 23-09, Torre Milton Salazar, Primer piso, El Bosque, 681004 Floridablanca, Santander, Colombia. jplopezj@gmail.com
Telephone: +57-7-6386000 Fax: +57-7-6388108
Received: August 25, 2014
Revised: October 25, 2014
Accepted: November 17, 2014
Published online: December 15, 2014
Revised: October 25, 2014
Accepted: November 17, 2014
Published online: December 15, 2014
Core Tip
Core tip: We propose that the current cut-points to define type 2 diabetes accepted by the World Health Organization need to be revaluated in populations such as the Latin America and that there should be lower cut points for glycaemia in this population, to reduce the prevalence of cardiovascular complications associated with diabetes mellitus type 2.